Clinical Trial Update: A Study of Vorinostat and Tamoxifen in Newly Diagnosed Breast Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating vorinostat in combination with tamoxifen for newly diagnosed breast cancer was terminated, with results posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Nolvadex (tamoxifen)
• Zolinza (vorinostat)

Snippet

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Conditions: Stage I Breast Cancer, Stage II Breast Cancer | Phase 2 | Status: TERMINATED | Results posted: 2013-05-17